|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
over 13 years ago
Emerging Pharma Leaders 2012over 13 years ago
Who Will Pay for New Drugs?over 13 years ago
Less, But Betterover 13 years ago
John Lechleiter on PhRMA and Innovationover 13 years ago
The Learning Curveover 13 years ago
Marketing: Why the Conversation Has Changed — ForeverNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
3
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5